Published in Eur J Cancer Clin Oncol on January 01, 1989
Does dexamethasone enhance control of acute cisplatin induced emesis by ondansetron? BMJ (1991) 1.02
Treatment of hyperemesis gravidarum with the 5-HT3 antagonist ondansetron (Zofran). Postgrad Med J (1996) 0.93
The pharmacokinetics of intravenous ondansetron in patients with hepatic impairment. Br J Clin Pharmacol (1993) 0.85
Effect of ondansetron on post-dural puncture headache (PDPH) in parturients undergoing cesarean section: a double-blind randomized placebo-controlled study. J Anesth (2015) 0.81
The pharmacokinetics of ondansetron after intravenous injection in healthy volunteers phenotyped as poor or extensive metabolisers of debrisoquine. Br J Clin Pharmacol (1994) 0.80
Pharmacogenetic predictors of nausea and vomiting of pregnancy severity and response to antiemetic therapy: a pilot study. BMC Pregnancy Childbirth (2013) 0.80
Safety by design. Drug Saf (1990) 0.78
Sir David Jack: an extraordinary drug discoverer and developer. Br J Clin Pharmacol (2013) 0.75
Mechanism of the prostanoid TP receptor agonist U46619 for inducing emesis in the ferret. Naunyn Schmiedebergs Arch Pharmacol (2008) 0.75
X. International Union of Pharmacology recommendations for nomenclature of new receptor subtypes. Pharmacol Rev (1996) 13.17
International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin). Pharmacol Rev (1994) 7.11
Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine. Neuropharmacology (1986) 5.83
Receptors for 5-hydroxytryptamine and noradrenaline in rabbit isolated ear artery and aorta. Br J Pharmacol (1976) 3.95
International union of pharmacology. XXIV. Current status of the nomenclature and properties of P2X receptors and their subunits. Pharmacol Rev (2001) 3.26
Comparison of the actions of U-46619, a prostaglandin H2-analogue, with those of prostaglandin H2 and thromboxane A2 on some isolated smooth muscle preparations. Br J Pharmacol (1981) 2.79
Studies on the characterisation of prostanoid receptors: a proposed classification. Prostaglandins (1982) 2.73
A quantitative study of metiamide, a histamine H2-antagonist, on the isolated whole rat stomach. J Physiol (1976) 2.56
GR32191, a highly potent and specific thromboxane A2 receptor blocking drug on platelets and vascular and airways smooth muscle in vitro. Br J Pharmacol (1989) 2.39
A comparison of 5-hydroxytryptamine receptors mediating contraction in rabbit aorta and dog saphenous vein: evidence for different receptor types obtained by use of selective agonists and antagonists. Br J Pharmacol (1985) 2.06
Classification and nomenclature of somatostatin receptors. Trends Pharmacol Sci (1995) 1.90
Evidence for two types of excitatory receptor for 5-hydroxytryptamine in dog isolated vasculature. Br J Pharmacol (1980) 1.86
Electrophysiological properties of P2X-purinoceptors in rat superior cervical, nodose and guinea-pig coeliac neurones. J Physiol (1995) 1.79
Two types of excitatory receptor for 5-hydroxytryptamine in dog vasculature? [proceedings]. Br J Pharmacol (1977) 1.67
GR113808: a novel, selective antagonist with high affinity at the 5-HT4 receptor. Br J Pharmacol (1994) 1.64
AH23848: a thromboxane receptor-blocking drug that can clarify the pathophysiologic role of thromboxane A2. Circulation (1985) 1.63
Rationale for the use of 5-HT1-like agonists in the treatment of migraine. J Neurol (1991) 1.61
Development of a radioligand binding assay for 5-HT4 receptors in guinea-pig and rat brain. Br J Pharmacol (1993) 1.56
5-Hydroxytryptamine-induced relaxation of isolated mammalian smooth muscle. Eur J Pharmacol (1983) 1.55
5-Hydroxytryptamine contracts human coronary arteries predominantly via 5-HT2 receptor activation. Eur J Pharmacol (1989) 1.55
Ionic effects on human recombinant P2X7 receptor function. Naunyn Schmiedebergs Arch Pharmacol (1999) 1.52
The effect of metiamide on acid secretion stimulated by gastrin, acetylcholine and dibutyryl cyclic adenosine 3',5'-monophosphate in the isolated whole stomach of the rat. Br J Pharmacol (1976) 1.48
Acute nociception mediated by hindpaw P2X receptor activation in the rat. Br J Pharmacol (1997) 1.46
Identification of putative 5-HT4 receptors in guinea-pig ascending colon. Eur J Pharmacol (1991) 1.46
International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. IX. Recommendations on terms and symbols in quantitative pharmacology. Pharmacol Rev (1995) 1.45
Blockade of human P2X7 receptor function with a monoclonal antibody. Blood (1998) 1.45
Peripheral 5-hydroxytryptamine receptors and their classification. Neuropharmacology (1984) 1.43
5-HT3 receptor antagonists injected into the area postrema inhibit cisplatin-induced emesis in the ferret. Br J Pharmacol (1989) 1.42
Further characterization of the 5-HT receptor mediating vascular relaxation and elevation of cyclic AMP in porcine isolated vena cava. Br J Pharmacol (1989) 1.39
A method for quantitating platelet aggregation and analyzing drug-receptor interactions on platelets in whole blood in vitro. J Pharmacol Methods (1981) 1.39
The selective carotid arterial vasoconstrictor action of GR43175 in anaesthetized dogs. Br J Pharmacol (1989) 1.39
Receptors for 5-hydroxytryptamine: current perspectives on classification and nomenclature. Neuropharmacology (1994) 1.37
Characterization of the 5-hydroxytryptamine receptor type involved in inhibition of spontaneous activity of human isolated colonic circular muscle. Br J Pharmacol (1994) 1.34
Pharmacological characterization of ATP- and LPS-induced IL-1beta release in human monocytes. Br J Pharmacol (1999) 1.34
5-HT1-like receptors mediate 5-hydroxytryptamine-induced contraction of human isolated basilar artery. Br J Pharmacol (1989) 1.31
Properties of the pore-forming P2X7 purinoceptor in mouse NTW8 microglial cells. Br J Pharmacol (1997) 1.30
Naratriptan: biological profile in animal models relevant to migraine. Cephalalgia (1997) 1.30
P2X receptor-mediated excitation of nociceptive afferents in the normal and arthritic rat knee joint. Br J Pharmacol (1998) 1.29
Effects of antagonists at the human recombinant P2X7 receptor. Br J Pharmacol (1998) 1.28
Ketanserin--a novel antihypertensive drug? J Pharm Pharmacol (1982) 1.28
U-46619, a selective thromboxane A2-like agonist? [proceedings]. Br J Pharmacol (1980) 1.28
The pharmacological characterization of 5-HT3 receptors in three isolated preparations derived from guinea-pig tissues. Br J Pharmacol (1990) 1.27
Characterization of 5-HT receptors mediating contraction of canine and primate basilar artery by use of GR43175, a selective 5-HT1-like receptor agonist. Br J Pharmacol (1989) 1.25
Vascular 5-HT1-like receptors that mediate contraction of the dog isolated saphenous vein and carotid arterial vasoconstriction in anaesthetized dogs are not of the 5-HT1A or 5-HT1D subtype. Br J Pharmacol (1991) 1.24
Cloning and functional characterisation of the mouse P2X7 receptor. FEBS Lett (1998) 1.21
Complexities of measuring antagonist potency at P2X(7) receptor orthologs. J Pharmacol Exp Ther (2001) 1.20
The effects of uptake1 on alpha-adrenoceptor antagonist potency in dog saphenous vein. Br J Pharmacol (1978) 1.19
5-Carboxamidotryptamine is a selective agonist at 5-hydroxytryptamine receptors mediating vasodilatation and tachycardia in anaesthetized cats. Br J Pharmacol (1986) 1.17
Functional characterization of the P2X(4) receptor orthologues. Br J Pharmacol (2000) 1.16
Adenosine nucleotides acting at the human P2Y1 receptor stimulate mitogen-activated protein kinases and induce apoptosis. J Biol Chem (2001) 1.16
The selective closure of feline carotid arteriovenous anastomoses (AVAs) by GR43175. Cephalalgia (1989) 1.16
Investigation into the 5-hydroxytryptamine receptor mediating smooth muscle relaxation in the rat oesophagus. Br J Pharmacol (1991) 1.15
Distribution and characterisation of [3H]alpha,beta-methylene ATP binding sites in the rat. Naunyn Schmiedebergs Arch Pharmacol (1993) 1.15
Apparent species differences in the kinetic properties of P2X(7) receptors. Br J Pharmacol (2000) 1.14
Presynaptic inhibitory action of 5-hydroxytryptamine in dog isolated saphenous vein. Br J Pharmacol (1979) 1.12
P2X1 receptor activation in HL60 cells. Blood (1996) 1.11
Excitatory effect of P2X receptor activation on mesenteric afferent nerves in the anaesthetised rat. J Physiol (1999) 1.11
Single-nucleotide polymorphism alleles in the insulin receptor gene are associated with typical migraine. Genomics (2001) 1.11
A study on P2X purinoceptors mediating the electrophysiological and contractile effects of purine nucleotides in rat vas deferens. Br J Pharmacol (1995) 1.09
5-Carboxamidotryptamine: a potent agonist mediating relaxation and elevation of cyclic AMP in the isolated neonatal porcine vena cava. Life Sci (1986) 1.09
Localization of P2X purinoceptor transcripts in the rat nervous system. Mol Pharmacol (1995) 1.08
Studies on the characterization of prostanoid receptors. Adv Prostaglandin Thromboxane Leukot Res (1983) 1.07
A pre-junctional action of 5-hydroxytryptamine and methysergide on noradrenergic nerves in dog isolated saphenous vein. J Pharm Pharmacol (1981) 1.06
Evidence for the existence of 5-hydroxytryptamine receptors, which are not of the 5-HT2 type, mediating contraction of rabbit isolated basilar artery. Br J Pharmacol (1986) 1.05
Somatostatin sst(2) receptor-mediated inhibition of mesenteric afferent nerves of the jejunum in the anesthetized rat. Gastroenterology (2001) 1.05
Chloride secretion in response to guanylin in colonic epithelial from normal and transgenic cystic fibrosis mice. Br J Pharmacol (1994) 1.05
Localization and functional expression of splice variants of the P2X2 receptor. Mol Pharmacol (1997) 1.04
Further evidence for two types of excitatory receptor for 5-hydroxytryptamine in dog vasculature [proceedings]. Br J Pharmacol (1977) 1.03
Investigation of the 5-hydroxytryptamine receptor mediating the 'maintained' short-circuit current response in guinea-pig ileal mucosa. Br J Pharmacol (1992) 1.02
Antagonist effects on human P2X(7) receptor-mediated cellular accumulation of YO-PRO-1. Br J Pharmacol (2000) 1.02
Characterization of purinoceptors mediating depolarization of rat isolated vagus nerve. Br J Pharmacol (1993) 1.01
Effects of divalent cations on the potency of ATP and related agonists in the rat isolated vagus nerve: implications for P2 purinoceptor classification. Br J Pharmacol (1994) 1.01
5-HT3 receptors. Med Res Rev (1990) 1.01
The effect of ranitidine on gastric acid secretory response curves to histamine, pentagastrin or bethanechol in the dog with a Heidenhain pouch. Agents Actions (1981) 1.00
Evidence for a presynaptic inhibitory receptor for 5-hydroxytryptamine in dog isolated saphenous vein [proceedings]. Br J Pharmacol (1978) 1.00
Investigation of the role of histamine H1-receptors in the control of gastric acid secretion in the rat. J Pharm Pharmacol (1978) 0.99
Activation of P2X receptors for adenosine triphosphate evokes cardiorespiratory reflexes in anaesthetized rats. J Physiol (1998) 0.99
Alignment of receptor nomenclature with the human genome: classification of 5-HT1B and 5-HT1D receptor subtypes. Trends Pharmacol Sci (1996) 0.99
Estimates of antagonist affinities at P2X purinoceptors in rat vas deferens. Eur J Pharmacol (1994) 0.99
The use of antagonists to characterize the receptors mediating depolarization of the rat isolated vagus nerve by alpha, beta-methylene adenosine 5'-triphosphate. Br J Pharmacol (1994) 0.98
5-HT1D binding sites in porcine brain can be sub-divided by GR43175. Br J Pharmacol (1989) 0.98
The selective P2X purinoceptor agonist, beta,gamma-methylene-L-adenosine 5'-triphosphate, discriminates between smooth muscle and neuronal P2X purinoceptors. Naunyn Schmiedebergs Arch Pharmacol (1995) 0.98
Differences in response to 5-HT4 receptor agonists and antagonists of the 5-HT4-like receptor in human colon circular smooth muscle. Br J Pharmacol (1995) 0.97
Role of 5-HT1-like receptors in the reduction of porcine cranial arteriovenous anastomotic shunting by sumatriptan. Br J Pharmacol (1991) 0.97
H2-receptor antagonists protect against aspirin-induced gastric lesions in the rat. Agents Actions (1981) 0.97
Comparative efficacies of three commercially available vaccines against West Nile Virus (WNV) in a short-duration challenge trial involving an equine WNV encephalitis model. Clin Vaccine Immunol (2007) 0.97
Relaxation of sheep cerebral arteries by vasoactive intestinal polypeptide and neurogenic stimulation: inhibition by L-NG-monomethyl arginine in endothelium-denuded vessels. Br J Pharmacol (1991) 0.97
Modification of the vasomotor actions of methysergide in the femoral arterial bed of the anaesthetized dog by changes in sympathetic nerve activity. J Auton Pharmacol (1981) 0.96
Effects of intravenous infusions of prostaglandin D2 in man. Prostaglandins (1984) 0.96
Tryptamine-induced vasoconstrictor responses in rat caudal arteries are mediated predominantly via 5-hydroxytryptamine receptors. Br J Pharmacol (1985) 0.96
Somatostatin receptors in Neuro2A neuroblastoma cells: ligand internalization. Br J Pharmacol (1997) 0.96
Comparison of the potencies of some prostaglandins as vasodilators in three vascular beds of the anaesthetised dog. Eur J Pharmacol (1982) 0.95
Somatostatin5 receptor-mediated [35S]guanosine-5'-O-(3-thio)triphosphate binding: agonist potencies and the influence of sodium chloride on intrinsic activity. Mol Pharmacol (1997) 0.95
5-HT(3) and histamine H(1) receptors mediate afferent nerve sensitivity to intestinal anaphylaxis in rats. Gastroenterology (2000) 0.95
The central site of the sympatho-inhibitory action of 5-hydroxytryptamine in the cat. Neuropharmacology (1987) 0.95
Presynaptic regulation of dopamine release in corpus striatum monitored in vitro in real time by fast cyclic voltammetry. Brain Res (1990) 0.95
Identification and characterization of an endogenous P2X7 (P2Z) receptor in CHO-K1 cells. Br J Pharmacol (1998) 0.94